Design of a phase 3, prospective, multicenter, open-label study of safety and hemostatic efficacy of rurioctocog alfa pegol in previously untreated patients <6 years of age with severe hemophilia A

被引：0
|
作者：
Mullins, E. [1 ,2 ]
Kefurt, C. [3 ]
Engl, W. [3 ]
Tangada, S. [4 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[3] Shire, Vienna, Austria
[4] Shire, Lexington, MA USA
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P095
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [41] A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Azacitidine in Previously Untreated Patients With TP53-Mutant Acute Myeloid Leukemia
    Daver, Naval
    Vyas, Paresh
    Chao, Mark P.
    Xing, Guan
    Renard, Camille
    Ramsingh, Giri
    Sallman, David A.
    Wei, Andrew H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S5 - S6
  • [42] Follow-up results of a prospective, multicenter, open-label study of oral fludarabine phosphate in patients with previously untreated B-CLL.
    Rossi, JF
    Van Hoof, A
    De Boeck, K
    Johnson, SA
    Bron, D
    Foussard, C
    Lister, TA
    Kramer, MHH
    Littlewood, TJ
    Marcus, RE
    Deconinck, E
    Guibon, O
    Montillo, M
    Tollerfield, SM
    BLOOD, 2005, 106 (11) : 602A - 602A
  • [43] A phase 3, multicenter, open-label safety study of vernakalant hydrochloride injection in patients with atrial fibrillation
    Stiell, I. G.
    Badenhorst, J. C. W.
    Kitt, T. M.
    Engel, D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 809 - 809
  • [44] Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III Study
    Xue, Feng
    Zhou, Hu
    Chen, Yun
    Sun, Jing
    Zeng, Xiaojing
    Jin, Chenghao
    Lei, Pingchong
    Li, Zhenyu
    Xi, Yaming
    Sun, Lirong
    Cui, Zhongguang
    Zhao, Xielan
    Yang, Linhua
    Zhang, Bangshuo
    Shen, Aizong
    Wu, Runhui
    Wang, Xiaolin
    Liu, Ling
    Wang, Yuhua
    Sun, Lizhi
    Xia, Yan
    Mo, Weichuan
    Yuan, Dong
    Lou, Jiwei
    Gan, Taiping
    Hu, Chengli
    Ling, Chen
    Su, Hongsheng
    Wang, Yali
    Tang, Baolin
    Yang, Renchi
    BLOOD, 2022, 140 : 8468 - 8469
  • [45] A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations
    Karelis, Guntis
    Balasa, Rodica
    De Bleecker, Jan L.
    Stuchevskaya, Tima
    Villa, Andres
    Van Damme, Philip
    Lagrange, Emmeline
    Heckmann, Jeannine M.
    Nicolle, Michael
    Vilciu, Crisandra
    Bril, Vera
    Mondou, Elsa
    Griffin, Rhonda
    Chen, Junliang
    Henriquez, Waleska
    Garcia, Beatriz
    Camprubi, Sandra
    Ayguasanosa, Jaume
    EUROPEAN NEUROLOGY, 2019, 81 (5-6) : 223 - 230
  • [46] Safety and Efficacy of Tixagevimab/Cilgavimab (Evusheld) in Autoimmune Inflammatory Rheumatic Disease Patients - a Prospective Multicenter Open-label Study
    Eviatar, Tali
    Furer, Victoria
    Kaufman, Ilana
    Levartovsky, David
    Elalouf, Ofir
    Zisman, Devy
    Gazitt, Tal
    Haddad, Amir
    Elias, Muna
    Feld, Joy
    Balbir-Gurman, Alexandra
    Moscovici, Yolanda Braun
    Pel, Sara
    Nevo, Sharon
    Paran, Daphna
    Elkayam, Ori
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 420 - 422
  • [47] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [48] Turoctocog alfa pegol (N8-GP) in severe hemophilia A: Longterm safety and efficacy in previously treated patients of all ages in the pathfinder8 study
    Lentz, Steven R.
    Kavakli, Kaan
    Klamroth, Robert
    Misgav, Mudi
    Nagao, Azusa
    Tosetto, Alberto
    Jorgensen, Pernille Juul
    Zak, Marek
    Nemes, Laszlo
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
  • [49] HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors
    Young, Guy
    Sidonio, Robert F.
    Liesner, Ri
    Oldenburg, Johannes
    Chang, Tiffany
    Uguen, Marianne
    Dhalluin, Christophe
    Schmitt, Christophe
    Levy, Gallia G.
    Shima, Midori
    Mahlangu, Johnny
    BLOOD, 2017, 130
  • [50] A prospective, open-label, multicenter, phase IV clinical study on the safety and efficacy of lobaplatin in the treatment of metastatic breast cancer.
    Xu, Binghe
    Yan, Min
    Ouyang, Quchang
    Han, Guohui
    Cheng, Ying
    Wang, Dewei
    Li, Ran
    Zhao, Da
    Sun, Tao
    Bai, Yuju
    Yu, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345